Published in Medical Letter on the CDC and FDA, November 19th, 2006
According to recent research from the United States, "Treatment goals for diabetic patients are directed towards lowering Ale values by controlling blood glucose concentrations (BGC), making it important to understand the relationship between the two parameters. Because findings from clinical trials about the relationship between BGC and HbA1c values show a profound variability around the obtained regression lines, they are difficult to apply to individual patients."
"Therefore," said S.M. Osterman-Golkar and H.W. Vesper,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.